Chang Chai‐fen, Zhang Zhuo-min, Liu Zi-xin, Gou Yong‐yi
{"title":"阴道给药16,16‐二甲基反式-Δ2‐PGE1甲酯(ONO 802)终止妊娠的临床研究","authors":"Chang Chai‐fen, Zhang Zhuo-min, Liu Zi-xin, Gou Yong‐yi","doi":"10.1111/J.1447-0756.1981.TB00536.X","DOIUrl":null,"url":null,"abstract":"A prostagladin analogue, 16-16-Dimethyl-trans-Δ2-PGE1 methyl ester from ONO Pharmaceutical Co., Ltd. was studied by the vaginal administration of suppositories for termination of early and 2nd trimesters of pregnancy. Clinical efficacy and side effects were observed and evaluated.","PeriodicalId":8557,"journal":{"name":"Asia-Oceania journal of obstetrics and gynaecology","volume":"37 1","pages":"315-318"},"PeriodicalIF":0.0000,"publicationDate":"2010-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical Studies on the Termination of Pregnancy by the Vaginal Administration of 16, 16‐Dimethyl—Trans—Δ2‐PGE1 methyl Ester (ONO 802)\",\"authors\":\"Chang Chai‐fen, Zhang Zhuo-min, Liu Zi-xin, Gou Yong‐yi\",\"doi\":\"10.1111/J.1447-0756.1981.TB00536.X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A prostagladin analogue, 16-16-Dimethyl-trans-Δ2-PGE1 methyl ester from ONO Pharmaceutical Co., Ltd. was studied by the vaginal administration of suppositories for termination of early and 2nd trimesters of pregnancy. Clinical efficacy and side effects were observed and evaluated.\",\"PeriodicalId\":8557,\"journal\":{\"name\":\"Asia-Oceania journal of obstetrics and gynaecology\",\"volume\":\"37 1\",\"pages\":\"315-318\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-05-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asia-Oceania journal of obstetrics and gynaecology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/J.1447-0756.1981.TB00536.X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia-Oceania journal of obstetrics and gynaecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/J.1447-0756.1981.TB00536.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Clinical Studies on the Termination of Pregnancy by the Vaginal Administration of 16, 16‐Dimethyl—Trans—Δ2‐PGE1 methyl Ester (ONO 802)
A prostagladin analogue, 16-16-Dimethyl-trans-Δ2-PGE1 methyl ester from ONO Pharmaceutical Co., Ltd. was studied by the vaginal administration of suppositories for termination of early and 2nd trimesters of pregnancy. Clinical efficacy and side effects were observed and evaluated.